Skip to main content
. Author manuscript; available in PMC: 2016 Dec 8.
Published in final edited form as: Curr Protoc Pharmacol. 2015 Dec 8;71:1.34.1–1.3421. doi: 10.1002/0471141755.ph0134s71

Table 10.

Sample conversion of total [3H]-DTG counts into nanomolar concentrations in assay

Targeted [3H]-DTG concentration (nM) Measured total radioactivity (DPM) Measured total [3H]-DTG (mmol) Measured [3H]-DTG concentration in assay (nM)
300 2337238 2.63E-08 310
100 693785.5 7.81E-09 92
30 204121.8 2.30E-09 27
10 67841.83 7.64E-10 9
3 20148.28 2.27E-10 2.7
1 6984 7.86E-11 0.8
0.3 2223 2.50E-11 0.25

The first column displays targeted concentrations of [3H]-DTG calculated from the stock vial (40 Ci/mmol or ~30 μM). Second column contains radioactivity counts in DPM of the targeted concentration of [3H]-DTG. Third column shows radioactivity values transformed from DPM into millimoles of radioligand (Note: the conversion factor used was 2.22 × 1012 DPM per Ci). The fourth column shows the actual concentrations of [3H]-DTG as calculated from the DPM values obtained.